Company intelligence / Profile preview

Partec

Görlitz, Saxony, Germany

Ownership: Private
Employees: ~180
Development stage: Other

Overview

Sysmex Partec is a pioneer in the field of flow cytometry and a leading manufacturer of high-precision diagnostic and research instrumentation. Founded in 1967 by Wolfgang Göhde, the company developed the first fluorescence-based flow cytometer. Today, it specializes in providing affordable, robust diagnostic solutions for global health, particularly for CD4 monitoring in HIV/AIDS patients in resource-limited settings. Following its acquisition by Sysmex Corporation in 2013, the company has expanded its portfolio to include advanced flow cytometry systems for immunology, microbiology, and industrial applications.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Device
Industry: Protein Biomarker Diagnostics

Partnerships

World Health OrganizationClinton Health Access InitiativeGöhde-Foundation

Beyond the preview

Go deeper on Partec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Partec.

Explore the full profile